메뉴 건너뛰기




Volumn 59, Issue 6, 2008, Pages 884-891

Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; PLACEBO;

EID: 45349108894     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23707     Document Type: Article
Times cited : (34)

References (14)
  • 1
    • 0035053927 scopus 로고    scopus 로고
    • A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score
    • for the International Network for the Study of the Systemic Vasculitides INSSYS
    • Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al, for the International Network for the Study of the Systemic Vasculitides (INSSYS). A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. Arthritis Rheum 2001;44:912-20.
    • (2001) Arthritis Rheum , vol.44 , pp. 912-920
    • Stone, J.H.1    Hoffman, G.S.2    Merkel, P.A.3    Min, Y.I.4    Uhlfelder, M.L.5    Hellmann, D.B.6
  • 2
    • 0028150660 scopus 로고
    • Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis
    • Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8.
    • (1994) QJM , vol.87 , pp. 671-678
    • Luqmani, R.A.1    Bacon, P.A.2    Moots, R.J.3    Janssen, B.A.4    Pall, A.5    Emery, P.6
  • 3
    • 23644432864 scopus 로고    scopus 로고
    • Current status of outcome measures in vasculitis: Focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7
    • for the Vasculitis Clinical Research Consortium
    • Merkel PA, Seo P, Aries P, Neogi T, Villa-Forte A, Boers M, et al, for the Vasculitis Clinical Research Consortium. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. J Rheumatol 2005;32:2488-95.
    • (2005) J Rheumatol , vol.32 , pp. 2488-2495
    • Merkel, P.A.1    Seo, P.2    Aries, P.3    Neogi, T.4    Villa-Forte, A.5    Boers, M.6
  • 4
    • 12544253745 scopus 로고    scopus 로고
    • Etanercept plus standard therapy for Wegener's granulomatosis
    • The Wegener's Granulomatosis Etanercept Trial (WGET) Re2 search Group
    • The Wegener's Granulomatosis Etanercept Trial (WGET) Re2 search Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005;352:351-61.
    • (2005) N Engl J Med , vol.352 , pp. 351-361
  • 5
    • 0037441919 scopus 로고    scopus 로고
    • Statistical analysis of correlated data using generalized estimating equations: An orientation
    • Hanley JA, Negassa A, Edwardes MD, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 2003;157:364-75.
    • (2003) Am J Epidemiol , vol.157 , pp. 364-375
    • Hanley, J.A.1    Negassa, A.2    Edwardes, M.D.3    Forrester, J.E.4
  • 6
    • 0036818274 scopus 로고    scopus 로고
    • Should scoring rules be based on odds ratios or regression coefficients? [letter]
    • Moons KG, Harrell FE, Steyerberg EW. Should scoring rules be based on odds ratios or regression coefficients? [letter]. J Clin Epidemiol 2002;55:1054-5.
    • (2002) J Clin Epidemiol , vol.55 , pp. 1054-1055
    • Moons, K.G.1    Harrell, F.E.2    Steyerberg, E.W.3
  • 7
    • 0001902550 scopus 로고
    • Cross-validation
    • Efron B, Tibshirani RJ, editors, New York: Chapman & Hall/CRC;
    • Efron B, Tibshirani RJ. Cross-validation. In: Efron B, Tibshirani RJ, editors. An introduction to the bootstrap. New York: Chapman & Hall/CRC; 1993. p. 239-41.
    • (1993) An introduction to the bootstrap , pp. 239-241
    • Efron, B.1    Tibshirani, R.J.2
  • 8
    • 0000629975 scopus 로고
    • Cross-validatory choice and assessment of statistical predictions
    • Stone M. Cross-validatory choice and assessment of statistical predictions. J Royal Stat Soc 1974;36:111-47.
    • (1974) J Royal Stat Soc , vol.36 , pp. 111-147
    • Stone, M.1
  • 10
    • 0043074578 scopus 로고    scopus 로고
    • Limited versus severe Wegener's granulomatosis: Baseline data on patients in the Wegener's granulomatosis etanercept trial
    • The Wegener's Granulomatosis Etanercept Trial Research Group
    • The Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 2003;48:2299-309.
    • (2003) Arthritis Rheum , vol.48 , pp. 2299-2309
  • 12
    • 23944478301 scopus 로고    scopus 로고
    • Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: Validation of a clinical activity score
    • Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7:R796-806.
    • (2005) Arthritis Res Ther , vol.7
    • Aletaha, D.1    Nell, V.P.2    Stamm, T.3    Uffmann, M.4    Pflugbeil, S.5    Machold, K.6
  • 13
    • 4644236004 scopus 로고    scopus 로고
    • A disease activity score for polymyalgia rheumatica
    • Leeb BF, Bird HA. A disease activity score for polymyalgia rheumatica. Ann Rheum Dis 2004;63:1279-83.
    • (2004) Ann Rheum Dis , vol.63 , pp. 1279-1283
    • Leeb, B.F.1    Bird, H.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.